Lopinavir
Brain Stem Glioma
Case Comprehensive Cancer CenterSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Brain Stem Glioma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
L-METHIONINE St. Jude Children's Research Hospital | Phase 2 | CCC |
RITONAVIR Case Comprehensive Cancer Center | Phase 2 | CCC |
Veliparib National Cancer Institute (NCI) | Phase 1/2 | CCC |
Therapeutic Allogeneic Lymphocytes City of Hope Medical Center | Phase 1 | CC |
Same molecule, other indications
Lopinavir is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →